Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioCryst Appoints New CFO

TheMotleyFool

0 0

BioCryst Pharmaceuticals (NASDAQ: BCRX) is making a big change within its C-suite. The company announced Thursday that it has appointed a new CFO, Anthony Doyle. It was not immediately clear when his tenure would begin.

Doyle comes to BioCryst from privately held research company Worldwide Clinical Trials Holdings, where he also filled the post of CFO starting in 2014. Prior to that, he was employed in a variety of financial positions at General Electric, and was CFO of World Book, owned by Warren Buffett's investment vehicle Berkshire Hathaway.

Image source: Getty Images.

Source Fool.com

Like: 0

BCRX

Share